文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

肝细胞癌中免疫细胞浸润景观的异质性及其免疫治疗意义。

The Heterogeneity of Immune Cell Infiltration Landscape and Its Immunotherapeutic Implications in Hepatocellular Carcinoma.

机构信息

Department of Pharmacy, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.

Henan Key Laboratory of Precision Clinical Pharmacy, Zhengzhou University, Zhengzhou, China.

出版信息

Front Immunol. 2022 Mar 10;13:861525. doi: 10.3389/fimmu.2022.861525. eCollection 2022.


DOI:10.3389/fimmu.2022.861525
PMID:35355983
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8959995/
Abstract

Immunotherapy, closely associated with immune infiltration and tumor mutation burden (TMB), is emerging as a promising strategy for treating tumors, but its low response rate in hepatocellular carcinoma (HCC) remains a major challenge. Herein, we applied two algorithms to uncover the immune infiltration landscape of the immune microenvironment in 491 HCC patients. Three immune infiltration patterns were defined using the CIBERSORT method, and the immune cell infiltration (ICI) scores were established using principal component analysis. In the high ICI score group, the activation of the Wnt/β-catenin pathway was significantly enriched and expressions of immune checkpoint genes increased, which showed a pessimistic outcome. The low ICI score group was characterized by increased TMB and enrichment of metabolism-related pathways. Further analysis found that the ICI score exhibited a significant difference in age ≥65/age <65, grade I/grade II-IV, and response to immunotherapy. Moreover, the CTNNB1 mutation status was found to be closely associated with prognosis and immunotherapeutic efficiency, significantly affecting the ICI score and TMB, which might be regarded as a potential marker for the treatment of HCC. The evaluation of immune infiltration patterns can improve the understanding of the tumor immune microenvironment and provide new directions for the study of individualized immunotherapy strategies for HCC.

摘要

免疫疗法与免疫浸润和肿瘤突变负担(TMB)密切相关,它正成为治疗肿瘤的一种有前途的策略,但在肝细胞癌(HCC)中的低反应率仍是一个主要挑战。在此,我们应用两种算法来揭示 491 例 HCC 患者免疫微环境中的免疫浸润情况。使用 CIBERSORT 方法定义了三种免疫浸润模式,并使用主成分分析建立了免疫细胞浸润(ICI)评分。在高 ICI 评分组中,Wnt/β-catenin 通路的激活明显富集,免疫检查点基因的表达增加,提示预后不良。低 ICI 评分组的特点是 TMB 增加和代谢相关途径的富集。进一步分析发现,ICI 评分在年龄≥65/年龄<65、分级 I/分级 II-IV 和对免疫治疗的反应方面存在显著差异。此外,发现 CTNNB1 突变状态与预后和免疫治疗效率密切相关,显著影响 ICI 评分和 TMB,这可能被视为治疗 HCC 的一个潜在标志物。免疫浸润模式的评估可以提高对肿瘤免疫微环境的理解,并为 HCC 的个体化免疫治疗策略研究提供新的方向。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b62e/8959995/288d24d79032/fimmu-13-861525-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b62e/8959995/32632b46a5ba/fimmu-13-861525-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b62e/8959995/9bcd6df7d030/fimmu-13-861525-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b62e/8959995/0de36b6099d4/fimmu-13-861525-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b62e/8959995/f4239cc79b6d/fimmu-13-861525-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b62e/8959995/c3002cfedec0/fimmu-13-861525-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b62e/8959995/b736f47c662a/fimmu-13-861525-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b62e/8959995/288d24d79032/fimmu-13-861525-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b62e/8959995/32632b46a5ba/fimmu-13-861525-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b62e/8959995/9bcd6df7d030/fimmu-13-861525-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b62e/8959995/0de36b6099d4/fimmu-13-861525-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b62e/8959995/f4239cc79b6d/fimmu-13-861525-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b62e/8959995/c3002cfedec0/fimmu-13-861525-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b62e/8959995/b736f47c662a/fimmu-13-861525-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b62e/8959995/288d24d79032/fimmu-13-861525-g007.jpg

相似文献

[1]
The Heterogeneity of Immune Cell Infiltration Landscape and Its Immunotherapeutic Implications in Hepatocellular Carcinoma.

Front Immunol. 2022

[2]
Exploration of Key Genes Combining with Immune Infiltration Level andTumor Mutational Burden in Hepatocellular Carcinoma.

Comb Chem High Throughput Screen. 2024

[3]
Identification of the immune cell infiltration landscape in pancreatic cancer to assist immunotherapy.

Future Oncol. 2021-11

[4]
Landscape of Immune Microenvironment Under Immune Cell Infiltration Pattern in Breast Cancer.

Front Immunol. 2021

[5]
CTNNB1 Alternation Is a Potential Biomarker for Immunotherapy Prognosis in Patients With Hepatocellular Carcinoma.

Front Immunol. 2021

[6]
m6A regulator-mediated methylation modification patterns and tumor microenvironment infiltration characterization in hepatocellular carcinoma.

Aging (Albany NY). 2021-8-30

[7]
N6-methyladenosine (m6A) RNA methylation regulator SNRPC is a prognostic biomarker and is correlated with immunotherapy in hepatocellular carcinoma.

World J Surg Oncol. 2021-8-13

[8]
Comprehensive analysis of tumour mutation burden and the immune microenvironment in hepatocellular carcinoma.

Int Immunopharmacol. 2020-12

[9]
Immune cell infiltration and immunotherapy in hepatocellular carcinoma.

Math Biosci Eng. 2022-5-16

[10]
Prognostic analysis of tumor mutation burden and immune infiltration in hepatocellular carcinoma based on TCGA data.

Aging (Albany NY). 2021-4-4

引用本文的文献

[1]
Single-Gene Mutations in Hepatocellular Carcinoma: Applications and Challenges in Precision Medicine.

Int J Med Sci. 2025-7-10

[2]
Targeting the PD-1/PD-L1 Signaling Pathway for Cancer Therapy: Focus on Biomarkers.

Int J Mol Sci. 2025-1-31

[3]
Study of TRAF3IP3 for prognosis and immune infiltration in hepatocellular carcinoma.

PeerJ. 2024-12-12

[4]
Expression Profile and Prognostic Significance of Pivotal Regulators for N7-Methylguanosine Methylation in Diffuse Large B-Cell Lymphoma.

Mol Biotechnol. 2024-10-22

[5]
Spatial analysis reveals targetable macrophage-mediated mechanisms of immune evasion in hepatocellular carcinoma minimal residual disease.

Nat Cancer. 2024-10

[6]
Comprehensive analysis of clinical and biological value of family genes in liver cancer.

World J Gastrointest Oncol. 2024-6-15

[7]
High LGALS3 expression induced by HCP5/hsa-miR-27b-3p correlates with poor prognosis and tumor immune infiltration in hepatocellular carcinoma.

Cancer Cell Int. 2024-4-20

[8]
DCLK1 is Overexpressed and Associated with Immune Cell Infiltration in Hepatocellular Carcinoma.

Biochem Genet. 2024-12

[9]
SAMD13 serves as a useful prognostic biomarker for hepatocellular carcinoma.

Eur J Med Res. 2023-11-15

[10]
Pan-cancer analysis identifies RNF43 as a prognostic, therapeutic and immunological biomarker.

Eur J Med Res. 2023-10-17

本文引用的文献

[1]
Conserved pan-cancer microenvironment subtypes predict response to immunotherapy.

Cancer Cell. 2021-6-14

[2]
Single-cell protein activity analysis identifies recurrence-associated renal tumor macrophages.

Cell. 2021-5-27

[3]
Mutant KRAS triggers functional reprogramming of tumor-associated macrophages in colorectal cancer.

Signal Transduct Target Ther. 2021-4-9

[4]
Targeting tumor-associated macrophages to synergize tumor immunotherapy.

Signal Transduct Target Ther. 2021-2-23

[5]
B7-H3 targeted antibody-based immunotherapy of malignant diseases.

Expert Opin Biol Ther. 2021-5

[6]
Effect of age and sex on immune checkpoint expression and kinetics in human T cells.

Immun Ageing. 2020-11-4

[7]
The Crosstalk Between Tumor-Associated Macrophages (TAMs) and Tumor Cells and the Corresponding Targeted Therapy.

Front Oncol. 2020-11-3

[8]
Tumor Mutational Burden as a Predictive Biomarker in Solid Tumors.

Cancer Discov. 2020-12

[9]
Immune-Stromal Score Signature: Novel Prognostic Tool of the Tumor Microenvironment in Lung Adenocarcinoma.

Front Oncol. 2020-9-23

[10]
Tumor-Infiltrating Lymphocytes and Their Prognostic Value in Cutaneous Melanoma.

Front Immunol. 2020

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索